Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Study Of SKI-606 Administered As A Single Agent In Japanese Subjects With Philadelphia Chromosome Positive Leukemias

NCT00811070 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00811070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00811070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Study Of SKI-606 Administered As A Single Agent In Japanese Subjects With Philadelphia Chromosome Positive Leukemias
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2007
Completion date
June 30, 2015
Enrollment
63 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myelogenous leukemia